Patents by Inventor Evan CASSAVAUGH

Evan CASSAVAUGH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STABLE SUSTAINED RELEASE THERAPEUTIC COMPOSITIONS IN APROTIC POLAR SOLVENTS AND METHODS OF MANUFACTURING THE SAME
    Publication number: 20240238381
    Abstract: The present invention relates to the use of aprotic polar solvents and an ionization stabilizing agent to prepare storage stable sustained release therapeutic formulations by dissolving a therapeutic agent (active ingredient) in an aprotic polar solvent system that can then be administered to patients suffering from or predisposed to a variety of physical conditions or disorders, notably hypoglycemia.
    Type: Application
    Filed: March 26, 2024
    Publication date: July 18, 2024
    Applicant: Xeris Pharmaceuticals, Inc.
    Inventors: Evan CASSAVAUGH, Steven PRESTRELSKI
  • Stable sustained release therapeutic compositions in aprotic polar solvents and methods of manufacturing the same
    Patent number: 11964003
    Abstract: The present invention relates to the use of aprotic polar solvents and an ionization stabilizing agent to prepare storage stable sustained release therapeutic formulations by dissolving a therapeutic agent (active ingredient) in an aprotic polar solvent system that can then be administered to patients suffering from or predisposed to a variety of physical conditions or disorders, notably hypoglycemia.
    Type: Grant
    Filed: June 25, 2021
    Date of Patent: April 23, 2024
    Assignee: XERIS PHARMACEUTICALS, INC.
    Inventors: Evan Cassavaugh, Steven Prestrelski
  • STABLE SUSTAINED RELEASE THERAPEUTIC COMPOSITIONS IN APROTIC POLAR SOLVENTS AND METHODS OF MANUFACTURING THE SAME
    Publication number: 20210401945
    Abstract: The present invention relates to the use of aprotic polar solvents and an ionization stabilizing agent to prepare storage stable sustained release therapeutic formulations by dissolving a therapeutic agent (active ingredient) in an aprotic polar solvent system that can then be administered to patients suffering from or predisposed to a variety of physical conditions or disorders, notably hypoglycemia.
    Type: Application
    Filed: June 25, 2021
    Publication date: December 30, 2021
    Inventors: Evan CASSAVAUGH, Steven PRESTRELSKI